June 12, 2024
Scientists at Weill Cornell Medicine discovered a previously unknown link between two key pathways that regulate the immune system in mammals—a finding that impacts our understanding of chronic inflammatory bowel diseases (IBD). This family of disorders severely impacts the health and quality of life of more than 2 million people in the United States.
May 2, 2024
November 9, 2023
Introducing the Allen Discovery Center for Neuroimmune Interactions at the Icahn School of Medicine at Mount Sinai, Co-Led by Weill Cornell Medicine
September 7, 2022
Immune cells called group 3 innate lymphoid cells (ILC3s) play an essential role in establishing tolerance to symbiotic microbes that dwell in the human gastrointestinal tract, according to a study led by researchers at Weill Cornell Medicine.
August 29, 2022
A study of mice found that dietary sugar alters the gut microbiome, setting off a chain of events that leads to metabolic disease, pre-diabetes, and weight gain.
July 13, 2022
Immune cells called group 3 innate lymphoid cells (ILC3s) play an essential role in establishing tolerance to symbiotic microbes that dwell in the human gastrointestinal tract, according to a study led by researchers at Weill Cornell Medicine.
January 31, 2022
A growth factor protein produced by rare immune cells in the intestine can protect against the effects of inflammatory bowel disease (IBD), according to a new discovery from Weill Cornell Medicine researchers.
December 1, 2021
A group of immune cells that normally protect against inflammation in the gastrointestinal tract may have the opposite effect in multiple sclerosis (MS) and other brain inflammation-related conditions, according to a new study by Weill Cornell Medicine and NewYork-Presbyterian researchers.
August 17, 2021
An immune cell subset called innate lymphoid cells (ILC3s) protects against colorectal cancer, in part by helping to maintain a healthy dialogue between the immune system and gut microbes, according to a new study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
April 8, 2021
People with Crohn's disease are typically treated with powerful anti-inflammatory medications that act throughout their body, not just in their digestive tract, creating the potential for unintended, and often serious, side effects.
April 17, 2020
Sooner or later, most cancer patients develop resistance to the very chemotherapy drugs designed to kill their cancer, forcing oncologists to seek alternatives.
April 14, 2020
An iron-regulating molecule called hepcidin is produced by the immune system and restricts the growth of gut bacteria after an intestinal injury, helping to heal the lining of the intestine, according to a study by Weill Cornell Medicine, NewYork-Presbyterian and Institut Cochin investigators.
May 1, 2019
The American Association of Immunologists (AAI) has named La Jolla Institute for Immunology (LJI) President and Chief Scientific Officer Dr. Mitchell Kronenberg, a world expert in T cell biology, as an AAI 2019 Distinguished Fellow.
April 30, 2019
Two physician-scientists at Washington University School of Medicine in St. Louis are among the 100 new members and 25 foreign associates elected to the National Academy of Sciences this year.
November 29, 2018
The awards provide $500,000 over five years to each recipient to support investigators at the Assistant Professor level to study microbial pathogenesis, with a focus on the interplay between human and microbial biology in order to shed light on how human and microbial systems are affected by their encounters.
October 16, 2017
Recognized for distinguished contributions to medicine and health
August 9, 2017
Dr. Gregory Sonnenberg, an assistant professor of microbiology and immunology at Weill Cornell Medicine, has received the newly established Young Investigator Award from the Society for Mucosal Immunology.
Background
Project Investigators
Photo: Color-enhanced histologic image showing intestinal tissue damange in a murine model of intestinal inflammation. Photo Credit: Artis and Sonnenberg laboratories, Weill Cornell Medical College.